The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2023 | Using single-cell RNA sequencing & proteomics to identify novel cell surface targets in AML
In this video, Veronique Lisi, PhD, CHU Sainte-Justine Research Centre, Montreal, Canada, briefly discusses how single-cell RNA sequencing and proteomics are being used to identify novel therapeutic targets in acute myeloid leukemia (AML). This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
